Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma.
BACKGROUND
A preliminary animal study was performed to determine if hepatic micrometastases from uveal melanoma secrete vascular endothelial growth factor (VEGF) that is measurable in serum.


METHODS
We analysed the serum of a C57Bl/6 mouse model of uveal melanoma (n=10) at days 4, 7, 14 and 21 post-inoculation for VEGF levels. We compared the serum VEGF levels with the number and location of hepatic micrometastases and their respective expression of VEGF mRNA.


RESULTS
Serum VEGF levels rose after inoculation of C57Bl/6 mice eyes with B16LS9 cutaneous melanoma cells. Beginning on day 14 there was a statistically significant (p<0.05) increase in VEGF levels, rising to an average peak level of 37.985 pg/ml at day 21. Peak serum VEGF levels correlated with the total number of hepatic micrometastases (R=0.444) and there was moderate correlation of peak VEGF serum levels with micrometastases in more hypoxic locations (R=0.572). VEGF mRNA expression by micrometastases was highest in the most hypoxic regions of the hepatic lobule.


CONCLUSIONS
Hepatic micrometastastic melanoma arising in a mouse model of ocular melanoma secretes VEGF. The number and location of the micrometastases correlate with serum VEGF levels.
Crosby
Michelle B
MB
Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Yang
Hua
H
Gao
Weiqing
W
Zhang
Lane
L
Grossniklaus
Hans E
HE
D000818:Animals; D005260:Female; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000378:metabolism* / Q000556:secondary*; D008545:Melanoma / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D009363:Neoplasm Proteins / Q000378:metabolism*; D014604:Uveal Neoplasms / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D000098943:Uveal Melanoma
D009363:Neoplasm Proteins; D042461:Vascular Endothelial Growth Factor A
Clin Exp Metastasis. 2008;25(5):509-16
18335317
Ophthalmol Clin North Am. 2005 Mar;18(1):75-84, viii
15763193
Br J Ophthalmol. 2002 Apr;86(4):448-52
11914216
Dis Colon Rectum. 2009 May;52(5):993-9
19502868
Arch Ophthalmol. 2006 Oct;124(10):1428-34
17030710
Am J Pathol. 1998 Sep;153(3):865-73
9736035
Cancer Res. 1976 Sep;36(9 pt.1):3160-5
975082
Melanoma Res. 2000 Feb;10(1):2-8
10711634
Ophthalmology. 2003 May;110(5):956-61
12750097
Mol Vis. 2006 May 22;12:511-7
16735992
Curr Eye Res. 2006 Sep;31(9):775-85
16966150
Ophthalmic Res. 2007;39(1):40-4
17164576
Int J Colorectal Dis. 2009 Mar;24(3):269-74
19084972
Invasion Metastasis. 1994-1995;14(1-6):349-61
7657528
Invest Ophthalmol Vis Sci. 2010 May;51(5):2329-37
20042655
Anticancer Res. 2004 Nov-Dec;24(6):4255-8
15736481
Invest Ophthalmol Vis Sci. 1987 Sep;28(9):1599-604
3623843
J Bone Joint Surg Br. 2009 Jun;91(6):784-8
19483233
Am J Ophthalmol. 1998 Jun;125(6):767-78
9645715
Br J Ophthalmol. 2000 Jul;84(7):750-6
10873988
Clin Cancer Res. 2000 Feb;6(2):572-7
10690541
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2835-42
20089875
Jpn J Ophthalmol. 2007 Sep-Oct;51(5):325-331
17926107